WebMarket Cap: 112.174M: Beta (5Y Monthly) 2.21: PE Ratio (TTM) N/A: EPS (TTM)-0.6500: Earnings Date: Mar 24, 2024: Forward Dividend & Yield: N/A (N/A) Ex-Dividend Date: N/A: 1y Target Est: 9.40 Find out all the key statistics for GenSight Biologics S.A. (SIGHT.PA), including … Stocks sink after Fed minutes despite cooler inflation: Stock market news … PARIS, March 10, 2024--Regulatory News: GenSight Biologics (Euronext: SIGHT, … Find the latest GenSight Biologics S.A. (SIGHT.PA) stock discussion in Yahoo … WebScale renewals management without increasing cost. “Using Gainsight for renewal management has allowed us to both specialize and scale our Customer Success teams. …
ARGENX NV 0QW0 Market Stock London Stock Exchange
WebView GenSight Biologics S.A.'s Market Cap trends, charts, and more. GenSight Biologics's market cap is €97.557 million... Get the tools used by (smart) 2 investors. WebMar 24, 2024 · GenSight Biologics S.A. press release ( OTC:GSGTF ): FY GAAP EPS of -€0.63. The Company’s operating income reduced by 36.9% to €4.9 million in 2024 from €7.7 million in 2024. The Company’s... niloo shams realtor
GenSight Biologics ENXTPA:SIGHT Stock Report - Simply Wall St
WebView the latest GenSight Biologics S.A. (SIGHT) stock price, news, historical charts, analyst ratings and financial information from WSJ. WebGensight Biologics Market Capitalization is currently at 165.35 M. Market Capitalization is the total market value of Gensight Biologics' equity. It is one of many ways to value … WebGenSight’s Profile, Revenue and Employees. GenSight is a provider of project portfolio management software for the organizations. GenSight’s primary competitors include … nilorn east asia ltd login